NCT05727787View on ClinicalTrials.gov

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

NARecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

May 28, 2025

Study Completion Date

December 28, 2025

Conditions

Liver Cancer

Interventions

RADIATION

Stereotactic Body Radiation Treatment

Single fraction SBRT 27 Gy

Trial Locations (1)

66160

RECRUITING

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

Varian Medical Systems

All Listed Sponsors

collaborator

Varian Medical Systems

INDUSTRY

lead

University of Kansas Medical Center

OTHER